Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of December 20, 2024 • 12:00 AM ET

Date/Time Source News Release
12/18/2024 07:35 AM EST GlobeNewswire Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia
11/29/2024 08:05 AM EST GlobeNewswire Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
11/18/2024 08:40 AM EST GlobeNewswire Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
10/31/2024 08:35 AM EDT GlobeNewswire Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant
09/10/2024 06:35 AM EDT GlobeNewswire Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
08/14/2024 02:30 PM EDT GlobeNewswire Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic
08/07/2024 08:13 AM EDT GlobeNewswire Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
07/22/2024 04:45 PM EDT GlobeNewswire Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
07/19/2024 08:01 AM EDT GlobeNewswire Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
07/18/2024 08:25 AM EDT GlobeNewswire Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15
Page

Additional News

As of December 20, 2024 • 12:00 AM ET

Date/Time Source News Release
12/18/2024 09:00 AM EST InvestorBrandNetwork InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Advances Ketamine Implant Development with Pharmacokinetic Study
12/02/2024 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Partners with Kymanox to Advance Ketamine Implant Therapeutic for Chronic Pain
11/29/2024 09:47 AM EST Baystreet Silo Gains on Drug Tests
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Silo Pharma Inc.
11/18/2024 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Promising Preclinical Results for SPC-15 in Treating Severe Psychiatric Disorders
10/31/2024 09:15 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Reports Promising Results from Testing of Ketamine-Loaded Implant for Chronic Pain Relief
09/10/2024 10:31 AM EDT Invezz BioMedNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Reports on FDA Pre-IND Meeting to Advance Development of Lead Program
09/10/2024 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Reports on FDA Pre-IND Meeting to Advance Development of Lead Program
08/21/2024 05:52 PM EDT SeekingAlpha Silo Pharma files for secondary stock offering
08/15/2024 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO), Sever Pharma Expand Existing Agreement to Include Extrusion of Novel Ketamine Implant Therapeutic
Page